Sleeping Beauty‐mediated correction of Fanconi anemia type C

The Sleeping Beauty (SB) transposon system can insert defined sequences into chromosomes to direct the extended expression of therapeutic genes. Our goal is to develop the SB system for nonviral complementation of Fanconi anemia (FA), a rare autosomal recessive disorder accompanied by progressive bone marrow failure.

[1]  R. McIvor,et al.  Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer. , 2010, Human gene therapy.

[2]  J. Wagner,et al.  Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector , 2010, Gene Therapy.

[3]  J. Wagner,et al.  Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. , 2009, Blood.

[4]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[5]  Boris Jerchow,et al.  Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates , 2009, Nature Genetics.

[6]  Xiaoling Zhang,et al.  Oxidative stress in Fanconi anemia hematopoiesis and disease progression. , 2008, Antioxidants & redox signaling.

[7]  Hanno Glimm,et al.  High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.

[8]  Weidong Wang.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins , 2007, Nature Reviews Genetics.

[9]  I. Shih,et al.  Measurement of Cyclin E Genomic Copy Number and Strand Length in Cell-Free DNA Distinguish Malignant versus Benign Effusions , 2007, Clinical Cancer Research.

[10]  L. Belur,et al.  Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon‐mediated gene delivery: implications for non‐viral gene therapy of mucopolysaccharidoses , 2007, The journal of gene medicine.

[11]  Pierre-Alexandre Vidi,et al.  Plastoglobules: a new address for targeting recombinant proteins in the chloroplast , 2007, BMC biotechnology.

[12]  J. Dausset,et al.  In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Carreau,et al.  Lack of Self‐Renewal Capacity in Fancc−/− Stem Cells After Ex Vivo Expansion , 2005, Stem cells.

[14]  M. L. Beau,et al.  Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. , 2005, Blood.

[15]  L. Belur,et al.  Counterselection and Co-Delivery of Transposon and Transposase Functions for Sleeping Beauty-Mediated Transposition in Cultured Mammalian Cells , 2004, Bioscience reports.

[16]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[17]  P. Hackett,et al.  Excision of Sleeping Beauty transposons: parameters and applications to gene therapy , 2004, The journal of gene medicine.

[18]  Sabine Fritz,et al.  Transposon mutagenesis of the mouse germline. , 2003, Genetics.

[19]  D. Largaespada,et al.  Gene transfer into genomes of human cells by the sleeping beauty transposon system. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  I. Verma,et al.  Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. , 2002, Blood.

[21]  P. Hackett,et al.  Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon. , 2002, Journal of molecular biology.

[22]  S. Olson,et al.  The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. , 2001, Blood.

[23]  J. Wagner,et al.  Somatic mosaicism in Fanconi anemia: Evidence of genotypic reversion in lymphohematopoietic stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Fagerlie,et al.  The Fanconi Anemia Protein FANCC Binds to and Facilitates the Activation of STAT1 by Gamma Interferon and Hematopoietic Growth Factors , 2000, Molecular and Cellular Biology.

[25]  M. Kay,et al.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system , 2000, Nature Genetics.

[26]  C. Ra,et al.  DNA induces apoptosis in electroporated human promonocytic cell line U937. , 2000, Biochemical and biophysical research communications.

[27]  C. Walsh,et al.  Phenotypic correction of Fanconi anemia group C knockout mice. , 2000, Blood.

[28]  S. Hui,et al.  Apoptosis induced by DNA uptake limits transfection efficiency. , 1999, Experimental cell research.

[29]  M. Grompe,et al.  In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. , 1999, Blood.

[30]  M. Buchwald,et al.  Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. , 1998, Blood.

[31]  R. Plasterk,et al.  Molecular Reconstruction of Sleeping Beauty , a Tc1-like Transposon from Fish, and Its Transposition in Human Cells , 1997, Cell.

[32]  H. Joenje,et al.  Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer. , 1997, Blood.

[33]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[34]  Gordon Royle,et al.  Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. , 1997, Blood.

[35]  David A. Williams,et al.  Stem cell collection and gene transfer in Fanconi anemia. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  D. Largaespada,et al.  Sleeping beauty transposon-mediated gene therapy for prolonged expression. , 2005, Advances in genetics.

[37]  M. Ahmad,et al.  Molecular mechanisms of N-acetylcysteine actions , 2003, Cellular and Molecular Life Sciences CMLS.